Healthcare >> CEO Interviews >> May 10, 1999
CHARLES W. BISHOP is President and CEO of Bone Care International, Inc.,
a public pharmaceutical company focused on developing and
commercializing vitamin D hormone therapies for a broad spectrum of
indications. Under Dr. Bishop's direction, Bone Care has advanced a
portfolio of proprietary vitamin D hormones and analogs to varying
stages of development for secondary hyperparathyroidism, metabolic bone
disease, psoriasis and cancers of the prostate, breast and colon. Dr.
Bishop joined Bone Care International in 1987 as Project Director, and
was named Vice President in 1990, and President in 1996. He has served
as a director of Bone Care since 1989. Prior to joining the Company, Dr.
Bishop worked as a Group Leader in the Health Care Division of the
Procter & Gamble Company. He completed a four-year National Institutes
of Health Postdoctoral Fellowship in Vitamin D Biochemistry at the
University of Wisconsin-Madison. Dr. Bishop received his PhD degree in
Nutritional Biochemistry from Virginia Polytechnic Institute and State
University, after earning an undergraduate degree in Chemistry from the
University of Virginia. Profile
enough information to put us into context as to what you see as your
business, and what you see as your company today?
Mr.
